MedTrace Logo

Scapulothoracic Joint Mobilization With or Without Acromioclavicular Joint Mobilization in Sub-acromial Pain Syndrome

NCT07331597 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-02-19

No results posted yet for this study

Summary

the study was conducted to find out the effects of scapulothoracic joint mobilization with or without acromioclavicular joint mobilization in patients with sub-acromial pain syndrome.

Conditions

  • Subacromial Pain Syndrome

Interventions

OTHER

Scapulothoracic joint mobilization

during 1st week of treatment, patients received Maitland grade-II mobilization for upward rotation, posterior tilting and external rotation glide, 5-10 oscillations per minute, 3 sets with 10 repetitions with 30 seconds rest interval. during 2nd, 3rd and 4rth week, patients received grade- II and III Maitland mobilization for upward rotation, posterior tilting and external rotation glide, 3 sessions a week for 4 weeks

OTHER

Acromioclavicular joint mobilization

during 1st week : Maitland grade-II mobilization for AC joint inferior glide, 5-10 oscillations per minute, 3 sets with 10 repetitions with 30 seconds rest interval. during 2nd, 3rd and 4rth week : Maitland grade-II, III for AC joint inferior glide, 5-10 oscillations per minute, 3 sets with 10 repetitions with 30 seconds rest interval, 3 sessions a week for 4 weeks.

OTHER

Standard physiotherapy treatment

Moist hot pack for 10-15 minutes on shoulder region in supine lying position. TENS modulated mode for 10 minutes. Scapular stabilization exercises including: scapular protraction and retraction, shoulder extension, shoulder external rotation, standing snow angels, standing weight shift, ball stabilization exercise, serratus anterior punch. 3 sets with 10 repetitions, 3 sessions a week for 4 weeks.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Saba Rafiq, MS-OMPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-10
Primary Completion
2025-07-10
Completion
2025-11-20

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07331597 on ClinicalTrials.gov